GenAI for the Enterprise
Transform How Your Research Team Works
Designed for HEOR, medical, and epidemiology teams, this GenAI-powered application removes the friction of legacy analytics processes. From dynamic cohort creation to instant outcomes analysis and citation-backed insights, users get answers in minutes – not weeks – no programming required. Precision Explorer empowers teams to collaborate faster, validate hypotheses sooner, and unlock continuous evidence generation across oncology.
Bring Speed, Precision and Confidence to Clinical Development
This off-the-shelf SaaS solution combines rich real-world data with generative AI agents to dynamically design, evaluate, and adapt your clinical trial strategy. Sponsors can reduce costly amendments, avoid underperforming sites, and meet diversity and enrollment goals with precision. From first draft to final enrollment, Precision Trials transforms trial operations into a data-driven, agile process.
Bring Clarity to Complexity
This out-of-the-box SaaS solution unifies fragmented data sources – EHR, claims, and SDOH – into a single, powerful platform tailored for oncology commercialization. With rich clinical context, real-time data updates, and built in GenAI, teams can act faster, engage smarter, and win more often. Whether you’re preparing for launch or tracking adherence, Precision Commercial helps you move from strategy to execution without the lag.
A short, compelling subtitle for the feature.
A short, compelling subtitle for the feature.
Deploy what you need, deploy how you want --- with the only subscription you'll need!
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
Explore our latest research, case studies, product updates, and thought leadership from across ConcertAI's expansive platform.
Unifying multimodal data, advanced AI, and clinical expertise to transform research and care delivery in oncology and hematology.
Recommendations
Precision Trials provides a set of recommendations: